Insulin aspart protamine and insulin aspart Subcutaneous and Mogamulizumab
Determining the interaction of Insulin aspart protamine and insulin aspart Subcutaneous and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart protamine and insulin aspart Subcutaneous-Mogamulizumab-kpkc
- Insulin aspart protamine and insulin aspart Subcutaneous-Mogamulizumab-kpkc Intravenous
- Insulin aspart protamine and insulin aspart Subcutaneous-Molindone
- Insulin aspart protamine and insulin aspart Subcutaneous-Mometasone (Oral Inhalation)
- Insulin aspart protamine and insulin aspart Subcutaneous-Mometasone and Formoterol
- Insulin aspart protamine and insulin aspart Subcutaneous-Mometasone and formoterol Inhalation
- Mogamulizumab-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Mogamulizumab-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Mogamulizumab-Insulin Aspart Protamine Injection
- Mogamulizumab-Insulin aspart, recombinant Subcutaneous
- Mogamulizumab-Insulin degludec
- Mogamulizumab-Insulin Degludec (U-100) Prefilled Pens